Abstract
Because screening is offered by the medical profession to supposedly well women in the general public, there is a particular ethical responsibility to be certain that it is effective in its implicit purpose of saving lives, and that the level of benefit it offers outweighs its costs and disadvantages to the women concerned. A large amount of research has therefore been undertaken to measure the value of screening for breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shapiro S, Venet W, Strax P, Venet L: Periodic screening for breast cancer. In: The Health Insurance Plan Project and Its Sequelae, 1963–1986. John Hopkins University Press, Baltimore & London 1988
Shapiro S, Strax P, Venet L: Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971 (215):1777–1785
Tabar L, Fagerberg G, Duffy SW, Day NE: The Swedish Two-County trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health 1989 (43): 107–114
Andersson I, Aspegren K, Janzon L et al: Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. Br Med J 1988 (297):943–994
Roberts MM, Alexander FE, Anderson TJ et al: Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990 (335):241–246
Frisell J, Eklund G, Hellstrom L et al: Randomized study of mammography screening - preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991 (18):49–56
Moss SM, Draper GJ, Hardcastle JD, Chamberlain J: Calculation of sample size in trials for early diagnosis of disease. Int J Epidemiol 1987 (16):104–110
UK Trial of Early Detection of Breast Cancer. Breast cancer mortality after ten years in the UK Trial of Early Detection of Breast Cancer (submitted)
Calnan MW, Chamberlain J, Moss S: Compliance with a class teaching breast self-examination. J Epidemiol Community Health 1983 (37–4):264–270
Collette HJA, Day NE, Rombach JJ, de Waard F: Evaluation of screening for breast cancer in a non- randomised study (the DOM Project) by means of a case-control study. Lancet 1984 (i):1224–1225
Day NE: Screening for Breast Cancer. Br Med Bull 1991 (47):400–415
Sasco AJ, Day NE, Walter SD: case-control studies for the evaluation of screening. J Chron Dis 1986 (39):399–405
Moss SM: Case-control studies of screening. Int J Epidemiol 1991 (20):1–6
Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE: Reduction of breast cancer mortality through mass screening with modern mammograph: first results of the Nijmegen project, 1975–1981. Lancet 1984 (i):1222–1224
Palli D, Rosselli del Turco M, Buiatti E, Carli S, Ciatto S, Toscani L, Maltoni GC: A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986 (38):501–504
Palli D, Rosselli del Turco M, Buiatti E, Ciatto S, Crocetti E, Paci F: Time intervals since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Health 1989 (43):241–248
Miller AB, Baines CJ, To T, Wall C: The Canadian National Breast Screening Study. In: Cancer Screening. Miller AB, Chamberlain J, Day NE (eds). Hakama M & Prorok PC. Cambridge University Press, 1991 pp 45–55
UKCCCR Subcommittee on Breast Screening Research, UKCCCR-sponsored Research on Breast Cancer Screening. J. Public Health Med. In press
Tabar L, Fagerberg G, Day NE, Holmberg L: What is the optimum interval between mammography screening examinations? Br J Cancer 1987 (55):547–551
de Waard F, Collette HJA, Rombach JJ, Bannders van Halewijn EA, Honing C: The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chronic Dis 1984 (37–1):1–44
Powles TJ, Hardy SE, Ashley GM, et al: A pilot trial to evalute the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. Br J Cancer 1989 (60):126–131
Early Breast Cancer Trialists’ Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 1988 (319):1681–1692
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Chamberlain, J., Palli, D. (1993). Evidence of the Effectiveness of Breast Cancer Screening. In: Gad, A., Del Turco, M.R. (eds) Breast Cancer Screening in Europe. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78154-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-78154-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78156-8
Online ISBN: 978-3-642-78154-4
eBook Packages: Springer Book Archive